Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995, 92: 785-789.
Article
CAS
PubMed
Google Scholar
Maron BJ, Pelliccia A: The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006, 114: 1633-1644. 10.1161/CIRCULATIONAHA.106.613562.
Article
PubMed
Google Scholar
Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ: Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000, 342: 1778-1785. 10.1056/NEJM200006153422403.
Article
CAS
PubMed
Google Scholar
McKenna WJ, Behr ER: Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 2002, 87: 169-176. 10.1136/heart.87.2.169.
Article
PubMed
PubMed Central
Google Scholar
Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathies, part I. Circulation. 2001, 104: 2113-2116. 10.1161/hc4201.097429.
Article
CAS
PubMed
Google Scholar
Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE: Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998, 338: 1248-1257. 10.1056/NEJM199804303381802.
Article
CAS
PubMed
Google Scholar
Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux AC, Isnard R, Hagege A, Langlard JM, Bonne G, Richard P, Hainque B, Bouhour JB, Schwartz K, Komajda M: Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation. 1998, 97: 2230-2236.
Article
CAS
PubMed
Google Scholar
Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA: Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 1998, 31: 186-194. 10.1016/S0735-1097(97)00434-8.
Article
CAS
PubMed
Google Scholar
Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE: Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000, 343: 1688-1696. 10.1056/NEJM200012073432304.
Article
CAS
PubMed
Google Scholar
Ashrafian H, Watkins H: Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol. 2007, 49: 1251-1264. 10.1016/j.jacc.2006.10.073.
Article
CAS
PubMed
Google Scholar
Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003, 24: 1965-1991. 10.1016/S0195-668X(03)00479-2.
Article
PubMed
Google Scholar
Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M: Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J. 1999, 20: 93-102. 10.1053/euhj.1998.1145.
Article
CAS
PubMed
Google Scholar
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005.
Article
PubMed
Google Scholar
Zeller R, Ivandic BT, Ehlermann P, Mucke O, Zugck C, Remppis A, Giannitsis E, Katus HA, Weichenhan D: Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. J Mol Med. 2006, 84: 682-691. 10.1007/s00109-006-0056-2.
Article
CAS
PubMed
Google Scholar
Zehelein J, Kathoefer S, Khalil M, Alter M, Thomas D, Brockmeier K, Ulmer HE, Katus HA, Koenen M: Skipping of Exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen syndrome. J Biol Chem. 2006, 281: 35397-35403. 10.1074/jbc.M603433200.
Article
CAS
PubMed
Google Scholar
Gautel M, Zuffardi O, Freiburg A, Labeit S: Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?. Embo J. 1995, 14: 1952-1960.
CAS
PubMed
PubMed Central
Google Scholar
Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ: Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004, 44: 1903-1910. 10.1016/j.jacc.2004.07.045.
Article
CAS
PubMed
Google Scholar
Erdmann J, Raible J, Maki-Abadi J, Hummel M, Hammann J, Wollnik B, Frantz E, Fleck E, Hetzer R, Regitz-Zagrosek V: Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2001, 38: 322-330. 10.1016/S0735-1097(01)01387-0.
Article
CAS
PubMed
Google Scholar
Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C: Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet. 2005, 42: e59-10.1136/jmg.2005.033886.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, Yamasaki N, Furuno T, Takata J, Nishinaga M, Kimura A, Doi YL: Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese. J Am Coll Cardiol. 2005, 46: 1737-1743. 10.1016/j.jacc.2005.05.087.
Article
CAS
PubMed
Google Scholar
Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE: Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults. N Engl J Med. 2008
Google Scholar
Nanni L, Pieroni M, Chimenti C, Simionati B, Zimbello R, Maseri A, Frustaci A, Lanfranchi G: Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun. 2003, 309: 391-398. 10.1016/j.bbrc.2003.08.014.
Article
CAS
PubMed
Google Scholar
Chang AN, Potter JD: Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev. 2005, 10: 225-235. 10.1007/s10741-005-5252-6.
Article
CAS
PubMed
Google Scholar
Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE: Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation. 2002, 105: 446-451. 10.1161/hc0402.102990.
Article
CAS
PubMed
Google Scholar
Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M: Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003, 107: 2227-2232. 10.1161/01.CIR.0000066323.15244.54.
Article
PubMed
Google Scholar
Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T, Zolk O: Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res. 2005, 66: 33-44. 10.1016/j.cardiores.2005.01.004.
Article
CAS
PubMed
Google Scholar
Song L, Zou Y, Wang J, Wang Z, Zhen Y, Lou K, Zhang Q, Wang X, Wang H, Li J, Hui R: Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clin Chim Acta. 2005, 351: 209-216. 10.1016/j.cccn.2004.09.016.
Article
CAS
PubMed
Google Scholar
Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE: Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol. 2001, 38: 315-321. 10.1016/S0735-1097(01)01386-9.
Article
CAS
PubMed
Google Scholar
Cardim N, Perrot A, Santos S, Morgado P, Padua M, Ferreira S, Reis RP, Monteiro C, Ferreira T, Correia JM, Osterziel KJ: Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Rev Port Cardiol. 2005, 24: 1463-1476.
PubMed
Google Scholar
Jaaskelainen P, Kuusisto J, Miettinen R, Karkkainen P, Karkkainen S, Heikkinen S, Peltola P, Pihlajamaki J, Vauhkonen I, Laakso M: Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. J Mol Med. 2002, 80: 412-422. 10.1007/s00109-002-0323-9.
Article
CAS
PubMed
Google Scholar
Kabaeva Z, Perrot A, Pilz B, Schulz-Menger J, Mohr FW, Dietz R, Osterziel KJ: Returning hypertrophy after surgery in a patient with hypertrophic cardiomyopathy caused by a myosin-binding protein C mutation. Int J Cardiol. 2005, 100: 343-345. 10.1016/j.ijcard.2005.01.004.
Article
PubMed
Google Scholar
Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kubler W, Katus HA: Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest. 1997, 100: 475-482. 10.1172/JCI119555.
Article
CAS
PubMed
PubMed Central
Google Scholar